← Back to Search

Group I (smoke-free home program) for Tobacco-Related Cancer

N/A
Waitlist Available
Led By Michelle Kegler, DrPH, MPH
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* 18 years of age and older
* Self-report as being a smoker or living with a smoker
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 3 and 6 months
Awards & highlights

Summary

This clinical trial evaluates a smoke-free home intervention for reducing exposure to secondhand smoke from commercial tobacco in homes of participants who live in rural tribal communities. Smoke-free homes are an innovative and relatively untapped strategy for cancer prevention in rural tribal communities. Smoke-free policies, including those that target homes, can reduce exposure to secondhand smoke and support smoking cessation. Rural and racial/ethnic inequities intersect to increase tobacco-related harms among Indigenous populations. A smoke-free home program may improve the health of the household as well as impact smoking behavior among the family unit by reducing secondhand smoke exposure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 3 and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3 and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Self-Reported Smoke-Free Home
Secondary study objectives
Number of Cigarettes Smoked In the Home
Public Support for Smoke-Free Tribal Housing Assessed Via Telephone Interview
Secondhand Smoke (SHS) Exposure In The Home Assessed via Telephone Interview
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (smoke-free home program)Experimental Treatment2 Interventions
Participants receive the smoke-free home program, consisting of mailed educational information about smoke-free homes at enrollment and in weeks 4 and 6, and attend one coaching call in week 2.
Group II: Group II (waitlist control)Active Control2 Interventions
Participants receive usual care on study. Participants may optionally receive the smoke-free home program following the 6 months follow-up.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking Cessation Intervention
2005
N/A
~1800

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,751 Previous Clinical Trials
40,962,880 Total Patients Enrolled
Emory UniversityLead Sponsor
1,656 Previous Clinical Trials
2,572,483 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,739 Previous Clinical Trials
7,511,160 Total Patients Enrolled
~383 spots leftby Jan 2028